Creo Medical Group PLC
LSE:CREO

Watchlist Manager
Creo Medical Group PLC Logo
Creo Medical Group PLC
LSE:CREO
Watchlist
Price: 10.375 GBX -0.24%
Market Cap: 42.8m GBX

Intrinsic Value

The intrinsic value of one CREO stock under the Base Case scenario is hidden GBX. Compared to the current market price of 10.375 GBX, Creo Medical Group PLC is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

CREO Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Creo Medical Group PLC

Intrinsic Value History
Dive into the past to invest in the future

CREO looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if CREO is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about CREO?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is CREO valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Creo Medical Group PLC.

Explain Valuation
Compare CREO to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CREO?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Creo Medical Group PLC

Current Assets 31.7m
Cash & Short-Term Investments 20.5m
Receivables 6.3m
Other Current Assets 4.9m
Non-Current Assets 37.1m
Long-Term Investments 32.8m
PP&E 3.6m
Intangibles 700k
Current Liabilities 6m
Accounts Payable 3.6m
Other Current Liabilities 2.4m
Non-Current Liabilities 1.9m
Long-Term Debt 1.9m
Efficiency

Free Cash Flow Analysis
Creo Medical Group PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Creo Medical Group PLC

Revenue
2.2m GBP
Cost of Revenue
-1.2m GBP
Gross Profit
1m GBP
Operating Expenses
-11m GBP
Operating Income
-10m GBP
Other Expenses
26.9m GBP
Net Income
16.9m GBP
Fundamental Scores

CREO Profitability Score
Profitability Due Diligence

Creo Medical Group PLC's profitability score is hidden . The higher the profitability score, the more profitable the company is.

hidden
Profitability
Score

Creo Medical Group PLC's profitability score is hidden . The higher the profitability score, the more profitable the company is.

CREO Solvency Score
Solvency Due Diligence

Creo Medical Group PLC's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Negative Net Debt
Low D/E
hidden
Solvency
Score

Creo Medical Group PLC's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CREO Price Targets Summary
Creo Medical Group PLC

Wall Street analysts forecast CREO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CREO is 40.8 GBX with a low forecast of 40.4 GBX and a high forecast of 42 GBX.

Lowest
Price Target
40.4 GBX
289% Upside
Average
Price Target
40.8 GBX
293% Upside
Highest
Price Target
42 GBX
305% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Creo Medical Group PLC
does not pay dividends
Shareholder Yield

Current shareholder yield for CREO is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one CREO stock?

The intrinsic value of one CREO stock under the Base Case scenario is hidden GBX.

Is CREO stock undervalued or overvalued?

Compared to the current market price of 10.375 GBX, Creo Medical Group PLC is hidden .

Back to Top